New Search

If you are not happy with the results below please do another search

52 search results for:

11

Build Engagement through WhatsApp Business

/0 Comments/in
Build Engagement through WhatsApp Business In today's fast-paced life, effective communication is paramount. With WhatsApp Business, we enable our Partners in the Pharma Industry to reach their audiences with relevant, targeted, and compliant messages. Furthermore, it's beyond sending messages, as we open a direct line to the audience's most personal device. Supporting related projects—from omnichannel [...]
12

Return on Invesment of AI

/0 Comments/in
Return on Investment of AI Is your organization planning to initiate or expand its AI use to achieve next year’s objectives? We're excited to announce our upcoming webinar, "Return on Investment (ROI) of AI" in collaboration with the swiss health quality association (shqa) and dedicated to colleagues in Swiss affiliates. Building on the success of [...]
13

How do companies get value out of AI in Medical Affairs?

/0 Comments/in
How do companies get value out of AI in Medical Affairs? With budget season upon most organizations, the questions about where to invest and how to deliver growth results or realize efficiencies are top of mind. Reflecting on 18 months with generative AI solutions and continued exchanges and discussions about yet more transformative potential of [...]
14

Early Diagnosis in Rare Diseases: The Power of Technology

/0 Comments/in
Early Diagnosis in Rare Diseases: The Power of Technology In the complex world of rare diseases, early diagnosis is both critical and challenging. With over 7,000 known rare diseases affecting millions worldwide, the need for innovative diagnostic approaches has never been greater. At FFI Ventures, we collaborate closely with life-science industry partners to leverage cutting-edge [...]
16

FFI-Ventures partnerships: Veeva partner

FFI's partner network Partner: Veeva As a Veeva AI Partner, FFI-Ventures is at the forefront of integrating artificial intelligence with Veeva's industry-leading cloud solutions. We combine cutting-edge AI expertise with deep life sciences domain knowledge to help pharmaceutical and biotech companies accelerate product development, enhance market strategies, and optimize customer engagement. Our collaboration with Veeva [...]
17

Partners

FFI's partner network Partners To address your organization's most challenging issues, we've joined forces with a diverse network of top-tier partners to elevate the solutions we design and deliver. By leveraging this robust partner ecosystem, you gain the expertise of FFI, combined with the specialized capabilities of other industry-leading companies, ensuring you receive the most [...]
18

Boost your gen AI ROI: Scaling AI projects multiplies returns

/0 Comments/in
Boost Your ROI: Scaling AI Projects Multiplies Returns Successfully scaling generative AI projects can significantly boost your ROI. While initial returns from pilot projects may be limited, scaling these initiatives can yield three times the return compared to those that never move beyond the pilot stage. For every dollar invested in AI, companies see an [...]
19

ONERAY.AI Capability Update: Document Summarization & Discussion

/0 Comments/in
ONERAY.AI capability update Exciting update! Our private Hashtag#generativeAI solution OneRay.AI, co-created with Pharma and Biotech partners just released a capability update. This state-of-the-art tool now offers ad-hoc summarization and discussion for up to 5 documents simultaneously in a secure, Pharma-compliant environment. It supports multiple formats, including images and graphs, and validates with Hashtag#Veeva and approved [...]
20

Competencies that drive impact in Rare Diseases

/0 Comments/in
Competencies that drive impact in Rare Disease We contribute to the management of rare diseases by fostering collaboration between life-science companies, patients, and support networks at global scale. The journey to diagnose a rare disease often spans 6 to 8 years due to the complexity and rarity of these conditions, often compounded by misdiagnoses and [...]